William DeVaul
General Counsel chez MORPHIC HOLDING, INC.
Fortune : 810 621 $ au 31/03/2024
Profil
William D.
DeVaul is currently the Secretary & General Counsel at Morphic Therapeutic, Inc. and Morphic Holding, Inc. He previously worked as the Vice President-Intellectual Property at Evelo Biosciences, Inc. from 2015 to 2019 and as an Attorney at Cubist Pharmaceuticals LLC from 2003 to 2015.
He obtained his undergraduate degree from The Trustees of Columbia University in The City of New York and his graduate degree from Boston University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
0,05% | 16/01/2024 | 23 029 ( 0,05% ) | 810 621 $ | 31/03/2024 |
Postes actifs de William DeVaul
| Sociétés | Poste | Début |
|---|---|---|
| MORPHIC HOLDING, INC. | General Counsel | 01/02/2019 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | General Counsel | - |
Anciens postes connus de William DeVaul
| Sociétés | Poste | Fin |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/02/2019 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/02/2015 |
Formation de William DeVaul
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
